PAR 4.65% 22.5¢ paradigm biopharmaceuticals limited..

WANTED PARA-008 Trial Participants, page-11

  1. 1,307 Posts.
    lightbulb Created with Sketch. 296
    Skip - the new CEO of Medibank (David Koczkar) has knee OA, which I read about in the dear old Fin Review and has done training to drop weight and try to hold off knees replacements. I sent emails to the investor relations contacts of both Medibank and Paradigm to see if he could be a possible trial PARticipant.

    It wasn't just a marketing thought from my side but more that he sounds like a decent guy and a pretty good candidate. I got a response from Medibank that my email had been sent to their "trials" section but nothing more and nothing from PAR. I'm not sure about the protocols but maybe you could mention to Dr Bloom and see if his office could contact David Koczkar to see if he wants to be screened?

    Maybe a stretch bu t I love the idea of a positive, active person getting a chance to get a great treatment.

    violin


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
22.5¢
Change
0.010(4.65%)
Mkt cap ! $78.73M
Open High Low Value Volume
22.0¢ 23.5¢ 21.5¢ $288.5K 1.279M

Buyers (Bids)

No. Vol. Price($)
6 130626 22.5¢
 

Sellers (Offers)

Price($) Vol. No.
23.0¢ 60000 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.